Validation of a Questionnaire for Allodynia in Migraine.
NCT ID: NCT04580641
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
180 participants
OBSERVATIONAL
2020-10-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Migraine in Electrohypersensitive Patients
NCT04845152
A Research Study to Examine Cutaneous Allodynia and Cluster Headache
NCT00329836
The Prevalence of Osmophobia in Migraine and Tension-Type Headache Patients and Its Association With Migraine Symptoms Over a Period of 6 Months
NCT07329127
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
NCT04299958
Migraine Attack Pain Phase Prediction Study
NCT06459635
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
These 4 symptoms have been studied separately in previous studies but to date, there is no overall questionnaire evaluating these 4 sub-types of hypersensitivity. The investigators have constituted a questionnaire based on previous validated questionnaires that have been translated into French (Lipton et al., 2008 for cutaneous allodynia; Choi et al., 2009 for photophobia), a previous questionnaire validated in French (Khalfa et al, 2002 for phonophobia) and created a few questions for each of the 4 symptoms, including osmophobia.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with migraine
No medical intervention. All included subjects will filled in the questionnaire concerning migraine characteristics and associated symptoms.
Questionnaire
A self-administered questionnaire will be completed by each study subject
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
A self-administered questionnaire will be completed by each study subject
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 17 years.
* Written consent.
Exclusion Criteria
* Presence of dermatological comorbidities that could lead to sensorial or sensitive abnormalities
* Presence of ENT comorbidities that could lead to sensorial or sensitive abnormalities
* Significant cognitive dysfunction precluding proper completion of the self-administered questionnaire
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier Moisset, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU de Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH d'Annecy, Centre d'Etude et de Traitement de la Douleur
Annecy, , France
Cabinet de Neurologie
Clermont-Ferrand, , France
CHU de Clermont-Ferrand, Centre d'Etude et de Traitement de la Douleur
Clermont-Ferrand, , France
CHU de Clermont-Ferrand, Service de Neurologie
Clermont-Ferrand, , France
CH Emile Roux Le Puy en Velay, Service de Neurologie
Le Puy-en-Velay, , France
CHU de Lille, Service de Neurologie
Lille, , France
CHU de Lyon, Hôpital Pierre Wertheimer, Service de neurologie fonctionelle et épileptologie
Lyon, , France
Assistance Publique - Hôpitaux de Marseille, CHU La Timone, Centre d'Evaluation et Traitement de la Douleur
Marseille, , France
CHU de Montpellier, Service de Neurologie
Montpellier, , France
CHU de Nantes, Service de Neurologie
Nantes, , France
CHU de Nice, Département Evaluation et Traitement de la Douleur
Nice, , France
Assistance Publique - Hôpitaux de Paris, CHU Lariboisière, Service de Neurologie
Paris, , France
CHU de Rouen, Service de Neurologie
Rouen, , France
CH de Vichy, Service de Neurologie
Vichy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Choi JY, Oh K, Kim BJ, Chung CS, Koh SB, Park KW. Usefulness of a photophobia questionnaire in patients with migraine. Cephalalgia. 2009 Sep;29(9):953-9. doi: 10.1111/j.1468-2982.2008.01822.x. Epub 2009 Feb 27.
Lipton RB, Bigal ME, Ashina S, Burstein R, Silberstein S, Reed ML, Serrano D, Stewart WF; American Migraine Prevalence Prevention Advisory Group. Cutaneous allodynia in the migraine population. Ann Neurol. 2008 Feb;63(2):148-58. doi: 10.1002/ana.21211.
Khalfa S, Dubal S, Veuillet E, Perez-Diaz F, Jouvent R, Collet L. Psychometric normalization of a hyperacusis questionnaire. ORL J Otorhinolaryngol Relat Spec. 2002 Nov-Dec;64(6):436-42. doi: 10.1159/000067570.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RNI 2018 MOISSET (Q-MIGAL)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.